Moerland MA - Search Results

1

β-radiation reduces the reactivity of extracellular matrix proteins in intravascular brachytherapy (IVBT), resulting in decreased platelet adhesion.

Wu YP, Stella PR, Chen SF, Wang YT, Wang JY, Moerland MA, Pan SD, Zhang B, Li GY, Doevendans PA, de Groot PG. Wu YP, et al. Among authors: moerland ma. Int J Cardiol. 2012 May 3;156(3):283-8. doi: 10.1016/j.ijcard.2010.11.001. Epub 2010 Dec 3. Int J Cardiol. 2012. PMID: 21130508 Free article.

2

BEta versus Gamma Utrecht Trial-Cypher (BEGUT-CYPHER): Is intracoronary brachytherapy still superior to drug-eluting stents?

Stella PR, de Jaegere P, Battermann JJ, Bouma P, Moerland MA, Doevendans PA. Stella PR, et al. Among authors: moerland ma. Neth Heart J. 2004 Sep;12(9):389-393. Neth Heart J. 2004. PMID: 25696369 Free PMC article.

3

Feasibility of adequate dose coverage in permanent prostate brachytherapy using divergent needle insertion methods.

van den Bosch MR, Lips IM, Lagerburg V, van Vulpen M, Lagendijk JJ, Moerland MA. van den Bosch MR, et al. Among authors: moerland ma. Radiother Oncol. 2008 Jan;86(1):120-5. doi: 10.1016/j.radonc.2007.10.037. Epub 2007 Nov 26. Radiother Oncol. 2008. PMID: 18037520

4

Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy.

Hinnen KA, Battermann JJ, van Roermund JG, Moerland MA, Jürgenliemk-Schulz IM, Frank SJ, van Vulpen M. Hinnen KA, et al. Among authors: moerland ma. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1433-8. doi: 10.1016/j.ijrobp.2009.03.049. Epub 2009 Jun 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 19540075

5

Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate.

Roeloffzen EM, Monninkhof EM, Battermann JJ, van Roermund JG, Moerland MA, van Vulpen M. Roeloffzen EM, et al. Among authors: moerland ma. Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):76-84. doi: 10.1016/j.ijrobp.2010.01.022. Epub 2010 Jun 3. Int J Radiat Oncol Biol Phys. 2011. PMID: 20605364

6

Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.

Nomden CN, de Leeuw AA, Moerland MA, Roesink JM, Tersteeg RJ, Jürgenliemk-Schulz IM. Nomden CN, et al. Among authors: moerland ma. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1424-30. doi: 10.1016/j.ijrobp.2011.04.044. Epub 2011 Jun 12. Int J Radiat Oncol Biol Phys. 2012. PMID: 21669505 Clinical Trial.

7

Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints.

Peters M, van der Voort van Zyp J, Hoekstra C, Westendorp H, van de Pol S, Moerland M, Maenhout M, Kattevilder R, van Vulpen M. Peters M, et al. Radiother Oncol. 2015 Nov;117(2):262-9. doi: 10.1016/j.radonc.2015.08.018. Epub 2015 Sep 5. Radiother Oncol. 2015. PMID: 26349590

8

Rectal dose constraints for salvage iodine-125 prostate brachytherapy.

Peters M, Hoekstra CJ, van der Voort van Zyp JR, Westendorp H, van de Pol SM, Moerland MA, Maenhout M, Kattevilder R, van Vulpen M. Peters M, et al. Among authors: moerland ma. Brachytherapy. 2016 Jan-Feb;15(1):85-93. doi: 10.1016/j.brachy.2015.10.004. Epub 2015 Nov 21. Brachytherapy. 2016. PMID: 26614233

9

Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants.

Moerland MA, van Deursen MJ, Elias SG, van Vulpen M, Jürgenliemk-Schulz IM, Battermann JJ. Moerland MA, et al. Radiother Oncol. 2009 May;91(2):202-6. doi: 10.1016/j.radonc.2008.09.013. Epub 2008 Oct 22. Radiother Oncol. 2009. PMID: 18950884

10

Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.

Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Moerland MA, Witteveen PO, Schreuder HW, van Dorst EB, Jürgenliemk-Schulz IM. Nomden CN, et al. Among authors: moerland ma. Radiother Oncol. 2013 Apr;107(1):69-74. doi: 10.1016/j.radonc.2013.04.006. Epub 2013 Apr 29. Radiother Oncol. 2013. PMID: 23639580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page